Preoperative alpha blockade for normotensive pheochromocytoma: Is it necessary?

Journal of Hypertension

Volumn 29, Issue 12, 2011, Pages 2429-2432

  Shao, Yuan ^a   Chen, Ran ^a   Shen, Zhou Jun ^a   Teng, Ying ^a   Huang, Peng ^b   Rui, Wen Bin ^a   Xie, Xin ^a   Zhou, Wen Long ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Doxazosin; hemodynamic; normotensive; pheochromocytoma; preoperative management

Indexed keywords

DOXAZOSIN; GLYCERYL TRINITRATE; NORADRENALIN; PHENTOLAMINE; VASOACTIVE AGENT;

ADRENAL INCIDENTALOMA; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CANCER SURGERY; COLLOID; DEMOGRAPHY; FEMALE; FLUID THERAPY; HEART RATE; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMOTENSIVE PHEOCHROMOCYTOMA; PHEOCHROMOCYTOMA; PREOPERATIVE CARE; PRIORITY JOURNAL;

EID: 81355127259     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834d24d9     Document Type: Article

References (22)

1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005; 366:665-675.
2. van der Horst-Schrivers AN, Kerstens MN, Wolffenbuttel BH. Preoperative pharmacological management of phaeochromocytoma. Neth J. Med 2006; 64:290-295.
3. Agarwal A, Gupta S, Mishra AK, Singh N, Mishra SK. Normotensive pheochromocytoma: Institutional experience. World J. Surg 2005; 29:1185-1188.
4. Bravo EL, Tagle R. Pheochromocytoma: State-of-the-art and future prospects. Endocr Rev 2003; 24:539-553.
5. Prys-Roberts C. Phaeochromocytoma: Recent progress in its management. Br J. Anaesth 2000; 85:44-57.
6. Prys-Roberts C, Farndon JR. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J. Surg 2002; 26:1037-1042.
7. Zhu Y, He HC, Su TW, Wu YX, Wang WQ, Zhao JP, et al. Selective 1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma. Endocrine 2010; 38:254-259.
8. Chen H, Sippel RS, O'Dorisio MS, Vinik AI, Lloyd RV, Pacak K. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 2010; 39:775-783.
9. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, et al. Management of the clinically inapparent adrenal mass ('incidentaloma'). Ann Intern Med 2003; 138:424-429.
10. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev 1995; 16:460-484.
11. Anagnostis P, Karagiannis A, Tziomalos K, Kakafika AI, Athyros VG, Mikhailidis DP. Adrenal incidentaloma: A diagnostic challenge. Hormones (Athens) 2009; 8:163-184.
12. Sprung J, O'Hara JF Jr, Gill IS, Abdelmalak B, Sarnaik A, Bravo EL. Anesthetic aspects of laparoscopic and open adrenalectomy for pheochromocytoma. Urology 2000; 55:339-343.
13. Kocak S, Aydintug S, Canakci N. Alpha blockade in preoperative preparation of patients with pheochromocytomas. Int Surg 2002; 87:191-194.
14. Carvalho MR, Dias T, Rodrigues A, Machado AP, Esteves R, do Carmo I. Alpha blockade with doxazosin in pheochromocytoma-report of three cases. Rev Port Cardiol 2010; 29:299-308.
15. Williams DT, Dann S, Wheeler MH. Phaeochromocytoma: views on current management. Eur J. Surg Oncol 2003; 29:483-490.
16. Karel P, Jacques L, Graeme E. Treatment of pheochromocytoma: medical therapy and preparation for surgery. In: Pheochromocytoma. Diagnosis, localization and treatment. Hoboken, NJ: Blackwell Publishing; 2007. pp. 110-113.
17. Weingarten TN, Cata JP, O'Hara JF, Prybilla DJ, Pike TL, Thompson GB, et al. Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology 2010; 76:508.e6- e11.
18. Alabaster VA, Davey MJ. The alpha 1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology. Br J. Clin Pharmacol 1986; 21 (Suppl 1):S9-S17.
19. Elliott HL, Meredith PA, Vincent J, Reid JL. Clinical pharmacological studies with doxazosin. Br J. Clin Pharmacol 1986; 21 (Suppl 1):S27-S31.
20. Smyth P, Pringle S, Jackson G, Lorimer AR. 24 Hour control of blood pressure by once daily doxazosin: A multicentre double-blind comparison with placebo. Eur J. Clin Pharmacol 1988; 34:613-618.
21. Ceral J, Solar M. Doxazosin: Safety and efficacy in the treatment of resistant arterial hypertension. Blood Press 2009; 18:74-77.
22. Havlik RJ, Cahow CE, Kinder BK. Advances in the diagnosis and treatment of pheochromocytoma. Arch Surg 1988; 123:626-630.